Patel Mahesh V. 4
4 · Lipocine Inc. · Filed Jan 2, 2025
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Patel Mahesh V.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-02$4.86/sh+16,371$79,563→ 149,039 totalExercise: $4.86From: 2026-01-02Exp: 2035-01-02→ Common Stock (16,371 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on January 2, 2026, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years.